1.	ITIC (Imiquimod Therapy in Cervical Intraepithelial Neoplasia)-Trial Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: ITIC1.0, NCT00941252
2.	Phase I/II Randomized Study of Cytomegalovirus-Specific T-Cell Adoptive Transfer in Patients With Newly Diagnosed Glioblastoma Multiforme Who Are Recovering From Therapeutic Temozolomide-Induced Lymphopenia Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Diagnostic, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: DUMC-PRO00000580, PRO00000580, DUMC-SPORE Project 3, NCT00627224
3.	Phase II Randomized Study of Adjuvant gp100 Peptide Immunization With or Without Montanide ISA 51 and/or Imiquimod in Patients With Resected High-Risk Melanoma (Treatment Arms I-IV Closed to Accrual as of 1/11/08) Phase: Phase II Type: Treatment Status: Active Age: 16 and over Sponsor: NCI Protocol IDs: NCI-06-C-0069, 7676, NCI-7676, NCI-P6703, NCT00304057
4.	Study of Immune Responses to Influenza Vaccination With or Without Imiquimod Application in Untreated CLL Patients Phase: Phase II Type: Supportive care Status: Active Age: Not specified Sponsor: Other Protocol IDs: Eudract number: 2006-004902-16, LREC number: 06/Q2201/143, NCT00596336
5.	Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: 07-380, NCT00799110
6.	Phase II Study of Topical Imiquimod and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Patients With Advanced Stage Refractory Breast Cancer With Recurrent Chest Wall Disease or Cutaneous Metastases Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: UWCC-6578, UWCC-6578, FHCRC-6578, IR-6578, NCT00821964
7.	Imiquimod for Breast Cancer Patients With Chest Wall Recurrence or Skin Metastases Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: NYU 09-0225, NCT00899574
8.	Immunevasion of Human Papillomavirus (HPV) in Vulvar Intraepithelial Neoplasia 2/3 and Anogenital Warts and Efficiency and Mechanisms of Imiquimod Treatment Phase: Phase II Type: Prevention Status: Active Age: 18 to 50 Sponsor: Other Protocol IDs: _1.0, ISRCTN: 2008-004893-42, NCT00941811
9.	Phase I Study of pNGVL4a-Sig/E7(detox)/HSP70 DNA Vaccine and TA-HPV Vaccine With or Without Imiquimod in Patients With Human Papillomavirus 16-Positive Grade 3 Cervical Intraepithelial Neoplasia Phase: Phase I Type: Biomarker/Laboratory analysis, Prevention, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: JHOC-J0656, J0656, NA_00002176, NCT00788164
10.	Viral Load Determination and Biomarkers of High Risk Human Papillomavirus (HPV) - Types in HIV-Positive Men Phase: No phase specified Type: Natural history/Epidemiology, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 01 KI 0211, NCT00365729
11.	A Pilot Study of the Treatment of Facial Nodular and Nodulocystic Basal Cell Carcinoma With Double Curettage and Cautery Followed by Application of Imiquimod to the Base Phase: No phase specified Type: Treatment Status: Approved-not yet active Age: 49 to 89 Sponsor: Other Protocol IDs: WN07DE002, EudraCT No: 2007-001961-14, NCT00463359
12.	Pilot Study of Topical Imiquimod Therapy in Patients With Recurrent Extramammary Paget's Disease of the Vulva Phase: No phase specified Type: Diagnostic, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: MSKCC-07029, 07-029, NCT00504023
13.	Imiquimod 5% Cream for the Treatment of Periocular Basal Cell Carcinoma Phase: No phase specified Type: Treatment Status: Active Age: 18 to 90 Sponsor: Other Protocol IDs: 0559/07, NCT00803907
14.	Topical Imiquimod 5% Cream for Treatment of Cutaneous Neurofibromas in Adults With Neurofibromatosis 1 Phase: No phase specified Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 08-347, NCT00865644